PLx Pharma Winddown Corp., formerly PLx Pharma Inc., is a United States-based company. The Company is no longer into any business operations and it has filed voluntary petitions under Chapter 11 of the United States Bankruptcy Code..
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 740 |
| Three Month Average Volume | 443.7K |
| High Low | |
| Fifty-Two Week High | 0.7249 USD |
| Fifty-Two Week Low | 0 USD |
| Fifty-Two Week High Date | 04 Oct 2022 |
| Fifty-Two Week Low Date | 21 Sep 2023 |
| Price and Volume | |
| Current Price | 0 USD |
| Beta | 4 |
| Relative Price Change | |
| Four Week Relative Price Change | -99.48% |
| Thirteen Week Relative Price Change | -99.97% |
| Twenty-Six Week Relative Price Change | -100.00% |
| Fifty-Two Week Relative Price Change | -100.00% |
| Year-to-Date Relative Price Change | -100.00% |
| Price Change | |
| One Day Price Change | 0.00% |
| Thirteen Week Price Change | -99.97% |
| Twenty-Six Week Price Change | -100.00% |
| Five Day Price Change | 0.00% |
| Fifty-Two Week Price Change | -100.00% |
| Year-to-Date Price Change | -100.00% |
| Month-to-Date Price Change | -99.50% |
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | 1.8766 USD |
| Book Value Per Share (Most Recent Quarter) | 0.89921 USD |
| Tangible Book Value Per Share (Last Fiscal Year) | 1.80176 USD |
| Tangible Book Value Per Share (Most Recent Quarter) | 0.82848 USD |
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | -2.30875 USD |
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 0.34705 USD |
| Revenue Per Share (Trailing Twelve Months) | 0.16314 USD |
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | -99999.99 USD |
| Dividend Per Share (Trailing Twelve Months) | 0 USD |
| Dividend Per Share (5 Year) | -99999.99 USD |
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | -2.05704 USD |
| Excluding Extraordinary Items (Trailing Twelve Months) | -0.98768 USD |
| Normalized (Last Fiscal Year) | -2.05704 USD |
| Basic Excluding Extraordinary Items (Last Fiscal Year) | -2.05704 USD |
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | -0.98768 USD |
| Including Extraordinary Items (Last Fiscal Year) | -2.05704 USD |
| Including Extraordinary Items (Trailing Twelve Months) | -0.98768 USD |
| Cash | |
| Cash Per Share (Last Fiscal Year) | 2.51975 USD |
| Cash Per Share (Most Recent Quarter) | 0.88662 USD |
| Cash Flow Per Share (Last Fiscal Year) | -2.05214 USD |
| Cash Flow Per Share (Trailing Twelve Months) | -0.98581 USD |
| Free Cash Flow Per Share (Trailing Twelve Months) | -2.13033 USD |
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | -787 |
| Cash Flow Revenue (Trailing Twelve Months) | -1,306 |
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | -606.92% |
| Pretax Margin (Last Fiscal Year) | -561.95% |
| Pretax Margin (5 Year) | -940.51% |
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | 41.46% |
| Gross Margin (Trailing Twelve Months) | 4.46% |
| Gross Margin (5 Year) | -99,999.99% |
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | -496.95% |
| Operating Margin (Trailing Twelve Months) | -1,417.83% |
| Operating Margin (5 Year) | -921.67% |
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | -561.95% |
| Net Profit Margin (Trailing Twelve Months) | -606.92% |
| Net Profit Margin (5 Year) | -931.61% |
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | -99,999.99% |
| Tangible Book Value (5 Year) | -99,999.99% |
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | -99,999.99% |
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | -94.17% |
| Revenue Growth (3 Year) | 233.15% |
| Revenue Change (Trailing Twelve Months) | -31.32% |
| Revenue Per Share Growth | 137.81% |
| Revenue Growth (5 Year) | 121.71% |
| Capital Spending Debt | |
| Capital Spending (5 Year) | -99,999.99% |
| Total Debt (5 Year) | -99,999.99% |
| Dividends | |
| Dividend Growth (3 Year) | -99,999.99% |
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | 63.06% |
| EPS Change (Trailing Twelve Months) | 67.79% |
| EPS Growth (3 Year) | -99,999.99% |
| EPS Growth (5 Year) | -99,999.99% |
| EBITDA | |
| EBITDA (5 Year) | -99,999.99% |
| EBITDA (5 Year Interim) | -99,999.99% |
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | -99,999.99% |
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | 0 |
| Price to Tangible Book (Most Recent Quarter) | 0 |
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | -100,000 |
| Price to Free Cash Per Share (Trailing Twelve Months) | -100,000 |
| Net Debt | |
| Net Debt (Most Recent Quarter) | -25,834,000 |
| Net Debt (Last Fiscal Year) | -69,392,000 |
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 0 |
| Price to Sales (Trailing Twelve Months) | 0 |
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | -100,000 |
| PE Normalized (Last Fiscal Year) | -100,000 |
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | -100,000 |
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | 15 |
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | 15 |
| PE Including Extraordinary Items (Trailing Twelve Months) | -100,000 |
| Dividends | |
| Dividend Yield (5 Year) | -99,999.99% |
| Dividend Yield | -99,999.99% |
| Current Dividend Yield | 0.00% |
| Price to Book | |
| Price to Book (Last Fiscal Year) | 0 |
| Price to Book (Most Recent Quarter) | 0 |
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | 0 |
| Long Term Debt to Equity (Most Recent Quarter) | 0 |
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | -99,999.99% |
| Payout Ratio (Trailing Twelve Months) | -99,999.99% |
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | 6 |
| Quick Ratio (Most Recent Quarter) | 4 |
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | -100,000 |
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | -100,000 |
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | 6 |
| Current Ratio (Most Recent Quarter) | 5 |
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | -32,118,000 |
| Free Cash Flow (Trailing Twelve Months) | -59,335,340 |
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | -8 |
| Net Interest Coverage (Trailing Twelve Months) | -100,000 |
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | 0 |
| Total Debt to Equity (Most Recent Quarter) | 0 |
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | -89.34% |
| Return on Assets (Trailing Twelve Months) | -44.10% |
| Return on Assets (5 Year) | -73.51% |
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | -393.38% |
| Return on Equity (Trailing Twelve Months) | -134.26% |
| Return on Equity (5 Year) | -2,426.68% |
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | -105.02% |
| Return on Investment (Trailing Twelve Months) | -49.54% |
| Return on Investment (5 Year) | -89.58% |